Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nurix Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 25K | May 20, 2024 | Direct | ||
Biohaven Ltd. | Director | Stock Option (Right to Buy) | 16.6K | Apr 30, 2024 | Direct | ||
Biohaven Pharmaceutical Holding Co Ltd. | Director | Stock Options (Right to Buy) | 0 | Oct 3, 2022 | Direct |